394 related articles for article (PubMed ID: 17223266)
21. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
Wozniak MA; Itzhaki RF; Shipley SJ; Dobson CB
Neurosci Lett; 2007 Dec; 429(2-3):95-100. PubMed ID: 17980964
[TBL] [Abstract][Full Text] [Related]
23. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
24. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
25. beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells.
Samuelsson M; Fisher L; Iverfeldt K
Int J Mol Med; 2005 Sep; 16(3):449-53. PubMed ID: 16077954
[TBL] [Abstract][Full Text] [Related]
26. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
Cho S; Hu Y
Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
[TBL] [Abstract][Full Text] [Related]
27. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
29. IGF-1 promotes beta-amyloid production by a secretase-independent mechanism.
Araki W; Kume H; Oda A; Tamaoka A; Kametani F
Biochem Biophys Res Commun; 2009 Feb; 380(1):111-4. PubMed ID: 19167357
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.
Valerio A; Boroni F; Benarese M; Sarnico I; Ghisi V; Bresciani LG; Ferrario M; Borsani G; Spano P; Pizzi M
Eur J Neurosci; 2006 Apr; 23(7):1711-20. PubMed ID: 16623827
[TBL] [Abstract][Full Text] [Related]
31. Prion protein (PrPc) promotes beta-amyloid plaque formation.
Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
[TBL] [Abstract][Full Text] [Related]
32. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
Onyango IG; Tuttle JB; Bennett JP
Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
[TBL] [Abstract][Full Text] [Related]
33. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
34. CD40 promotion of amyloid beta production occurs via the NF-kappaB pathway.
Ait-Ghezala G; Volmar CH; Frieling J; Paris D; Tweed M; Bakshi P; Mullan M
Eur J Neurosci; 2007 Mar; 25(6):1685-95. PubMed ID: 17432959
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42.
Leuchtenberger S; Kummer MP; Kukar T; Czirr E; Teusch N; Sagi SA; Berdeaux R; Pietrzik CU; Ladd TB; Golde TE; Koo EH; Weggen S
J Neurochem; 2006 Jan; 96(2):355-65. PubMed ID: 16300630
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation amyloid beta-protein 42 production by interfering with transcript of presenilin 1 gene with siRNA.
Luo HM; Deng H; Xiao F; Gao Q; Weng W; Zhang PF; Li XG
Acta Pharmacol Sin; 2004 Dec; 25(12):1613-8. PubMed ID: 15569405
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production.
Gamerdinger M; Clement AB; Behl C
Mol Pharmacol; 2007 Jul; 72(1):141-51. PubMed ID: 17395689
[TBL] [Abstract][Full Text] [Related]
38. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
39. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.
Fu H; Li W; Luo J; Lee NT; Li M; Tsim KW; Pang Y; Youdim MB; Han Y
Biochem Biophys Res Commun; 2008 Feb; 366(3):631-6. PubMed ID: 18039469
[TBL] [Abstract][Full Text] [Related]
40. Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.
Paris D; Beaulieu-Abdelahad D; Bachmeier C; Reed J; Ait-Ghezala G; Bishop A; Chao J; Mathura V; Crawford F; Mullan M
Eur J Pharmacol; 2011 Nov; 670(2-3):384-91. PubMed ID: 21958873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
